Intrinsic Value of S&P & Nasdaq Contact Us

Cyclo Therapeutics, Inc. CYTHW NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
47/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — CYTHW

Cyclo Therapeutics, Inc. (CYTHW) has a market capitalization of $899.37K and trades at $0.03. The 52-week range is 0.025-0.614.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-1.23, annual revenue of $1.08M.

The stock has a beta of -0.57, operates in the Healthcare sector.

Trading Data
Current Price$0.03
52-Week Range0.025-0.614
Volume28.41K
Avg Volume (30D)12.32K
Market Cap$899.37K
Beta (1Y)-0.57
Company
IPO Date2020-12-18
Employees8
CEON. Scott Fine
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS23254X1101
CUSIP23254X110
Income (Latest Year)
Revenue$1.08M
Gross Profit$977.95K
EBITDA$-20.03M
Operating Income$-20.05M
Net Income$-20.06M
EPS$-1.23
EPS Diluted$-1.23
Shares Outstanding$16.33M
Balance Sheet (Latest Year)
Total Assets$13.25M
Current Assets$12.32M
Cash & ST Investments$9.25M
Total Liabilities$8.49M
Total Debt$1.03M
Net Debt$-8.21M
Total Equity$4.76M
Debt / Equity0.22
Valuation Ratios
P/E Ratio-0
P/S Ratio0.84
P/B Ratio0.19
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message